By Ali Mohammed Zanna, Maiduguri
The World Health Organization (WHO) has reported that an estimated 400,000 children worldwide develop cancer each year, with survival rates varying significantly between high-income and low-income countries.
WHO Director-General Dr. Tedros Ghebreyesus made this known during an online media conference on global health issues, stressing the need for urgent action to improve cancer treatment and survival rates, especially in developing nations.
He noted that while nearly 90% of children with cancer survive in high-income countries, the survival rate in many low- and middle-income countries remains below 30%.
To bridge this gap, WHO, in partnership with St. Jude Children’s Research Hospital and over 100 other global partners, has launched initiatives aimed at improving access to life-saving cancer medicines.
As part of this effort, WHO has begun distributing free childhood cancer medications in Mongolia and Uzbekistan, with plans to extend support to Ecuador, Jordan, Nepal, and Zambia.
Dr. Ghebreyesus stated that WHO’s long-term goal is to reach 120,000 children across 50 countries over the next five to seven years. He emphasized that early detection, timely treatment, and affordable medication are critical in reducing childhood cancer deaths.
Beyond cancer treatment, WHO continues to work on broader global health challenges, including emergency response efforts, polio eradication, and strengthening healthcare systems to ensure universal health coverage.
Health experts have called for increased investment in cancer treatment, particularly in developing nations, to ensure that children diagnosed with cancer have a fair chance of survival regardless of their country’s economic status.

